Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers.
Exercise, brain, and cognition across the life span.
Cognitive impairment among different clinical courses of multiple sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
The role of angiogenesis in the pathology of multiple sclerosis.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
The prevalence of multiple sclerosis in the city of Santos has remained unaltered for five years.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.
Exploring the potential of public proteomics data.
Imaging resting state brain function in multiple sclerosis.
[Neurodegeneration in multiple sclerosis and the neuroprotective effect of glatiramer acetate: a literature review].
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Multiple sclerosis: RBPJ identified as an autoantigen in multiple sclerosis.
Pages
« first
‹ previous
…
310
311
312
313
314
315
316
317
318
…
next ›
last »